Melanoma is a dangerous type of skin cancer that develops from the cells that produce melanin, known as melanocytes. This cancer can develop anywhere on the skin, although it’s most common on the backs of men and legs of women.
It can manifest as a new spot or a change in an existing freckle or mole. Symptoms of melanoma include:
- Changes in color
- An unusual border
- Uneven edges or shape
- Changes in symptoms, like bleeding or new itchiness
- Changes in size
New research published last month discussed a revolutionary artificial intelligence model that could transform how melanoma is detected. The research was conducted by researchers at Ahmadu Bello University, led by Aliyu Tetengi Ibrahim.
The researchers designed the model to harness the power of test time augmentation and transfer learning, which allowed to classify skin lesions into different categories. Test time augmentation is a method that enlarges a dataset artificially by applying random amendments to test pictures. This improves the ability of the model to generalize across an extensive range of skin lesions, enhancing diagnostic precision.
This advanced deep learning model merges 5 sophisticated transfer learning models to categorize skin lesions into classifications like benign keratosis, melanoma, and basal cell carcinoma, among others.
The model, which was trained on the HAM10000 dataset that has more than 10,000 dermoscopic pictures, recorded a 94.4% rate of accuracy. Ibrahim, the lead researcher, stated that the integration of deep learning in dermatology was a necessity.
He explained that the high accuracy rate of their model could promote earlier detection of melanoma and decrease the need for unnecessary biopsies, which could help save lives by assisting dermatologists to make well-informed decisions.
Ibrahim added that the progress they made was a clear example of how artificial intelligence could boost medical expertise while also offering crucial support in the fight against melanoma. The potential applications of this model in clinical settings are vast. For instance, it could simplify the diagnostic process, improve patient care in regions with limited access to dermatological knowledge, and decrease costs of health care.
Incorporating this tech into telemedicine platforms could also make melanoma diagnosis more affordable, providing advanced medical care to underserved communities.
By enhancing the accuracy of melanoma detection, this study marks a major advancement in dermatological research and has the potential to transform international health care, making assessments more affordable and accessible to people globally. The study’s findings were published in Data Science and Management.
Many tech companies, such as Meta Platforms Inc. (NASDAQ: META) are also developing AI models for use in a variety of applications. At this rate of innovation, this new technology could soon dominate all industries.
About AINewsWire
AINewsWire (“AINW”) is a specialized communications platform with a focus on the latest advancements in artificial intelligence (“AI”), including the technologies, trends and trailblazers driving innovation forward. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, AINW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, AINW brings its clients unparalleled recognition and brand awareness.
AINW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from AINewsWire, text “AI” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit www.AINewsWire.com
Please see full terms of use and disclaimers on the AINewsWire website applicable to all content provided by AINW, wherever published or re-published: https://www.AINewsWire.com/Disclaimer
AINewsWire
Los Angeles, CA
www.AINewsWire.com
310.299.1717 Office
Editor@AINewsWire.com
AINewsWire is powered by IBN